These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 11481566)

  • 1. Reduced myocardial flow reserve in anatomically normal coronary arteries due to elevated baseline myocardial blood flow in men with old myocardial infarction.
    Yonekura K; Yokoyama I; Ohtake T; Inoue Y; Aoyagi T; Sugiura S; Momose T; Otomo K; Nagai R
    J Nucl Cardiol; 2002; 9(1):62-7. PubMed ID: 11845131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond the cholesterol profile: monitoring therapeutic effectiveness of statin therapy.
    Schwartz RG
    J Nucl Cardiol; 2001; 8(4):528-32. PubMed ID: 11481576
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of ezetimibe-simvastatine over endothelial dysfunction in dyslipidemic patients: assessment by 13N-ammonia positron emission tomography.
    Alexanderson E; García-Rojas L; Jiménez M; Jácome R; Calleja R; Martínez A; Ochoa JM; Meave A; Alexanderson G
    J Nucl Cardiol; 2010 Dec; 17(6):1015-22. PubMed ID: 20737263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvascular Angina Diagnosed by Absolute PET Myocardial Blood Flow Quantification.
    Pelletier-Galarneau M; Dilsizian V
    Curr Cardiol Rep; 2020 Jan; 22(2):9. PubMed ID: 31993834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative cardiac positron emission tomography: the time is coming!
    Sciagrà R
    Scientifica (Cairo); 2012; 2012():948653. PubMed ID: 24278760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early insights of cardiac risk and treatment response with quantitative PET monitoring of coronary-specific endothelial dysfunction and myocardial perfusion reserve.
    Schwartz RG
    J Nucl Cardiol; 2010 Dec; 17(6):985-9. PubMed ID: 20963538
    [No Abstract]   [Full Text] [Related]  

  • 7. Impaired myocardial blood flow reserve in subjects with metabolic syndrome analyzed using positron emission tomography and N-13 labeled ammonia.
    Teragawa H; Morita K; Shishido H; Otsuka N; Hirokawa Y; Chayama K; Tamaki N; Kihara Y
    Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):368-76. PubMed ID: 19915835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired coronary flow velocity reserve and aortic distensibility in patients with untreated hypercholesterolemia--an echocardiographic study.
    Nemes A; Forster T; Csanády M
    Int J Cardiovasc Imaging; 2007 Feb; 23(1):15-23. PubMed ID: 16779615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The non-invasive documentation of coronary microcirculation impairment: role of transthoracic echocardiography.
    Dimitrow PP; Galderisi M; Rigo F
    Cardiovasc Ultrasound; 2005 Aug; 3():18. PubMed ID: 16080792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in positron emission tomography.
    Di Carli MF
    J Nucl Cardiol; 2004; 11(6):719-32. PubMed ID: 15592196
    [No Abstract]   [Full Text] [Related]  

  • 11. Benefits and risks of simvastatin in patients with familial hypercholesterolaemia.
    Mata P; Alonso R; Badimón J
    Drug Saf; 2003; 26(11):769-86. PubMed ID: 12908847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis.
    Yokoyama I; Ohtake T; Momomura S; Nishikawa J; Sasaki Y; Omata M
    Circulation; 1996 Dec; 94(12):3232-8. PubMed ID: 8989134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin treatment improves myocardial and peripheral blood flow in familial hypercholesterolemia subjects without evidence of coronary atherosclerosis.
    Lario FC; Miname MH; Tsutsui JM; Santos RD; Kowatsch I; Sbano JC; Ramires JA; Kalil Filho R; Mathias W
    Echocardiography; 2013 Jan; 30(1):64-71. PubMed ID: 22957727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Lozano P; Henrikson NB; Dunn J; Morrison CC; Nguyen M; Blasi PR; Anderson ML; Whitlock EP
    JAMA; 2016 Aug; 316(6):645-55. PubMed ID: 27532919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional myocardial blood flow and coronary reserve in hypertensive patients. The effect of therapy.
    Parodi O; Neglia D; Sambuceti G; Marabotti C; Palombo C; Donato L
    Drugs; 1992; 44 Suppl 1():48-55. PubMed ID: 1283584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effect of simvastatin on the improvement of impaired myocardial flow reserve in patients with familial hypercholesterolemia without gender variance.
    Yokoyama I; Yonekura K; Inoue Y; Ohtomo K; Nagai R
    J Nucl Cardiol; 2001; 8(4):445-51. PubMed ID: 11481566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced coronary flow reserve in familial hypercholesterolemia.
    Yokoyama I; Murakami T; Ohtake T; Momomura S; Nishikawa J; Sasaki Y; Omata M
    J Nucl Med; 1996 Dec; 37(12):1937-42. PubMed ID: 8970509
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.